tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Incyte upgraded to Overweight from Equal Weight at Wells Fargo

Wells Fargo upgraded Incyte (INCY) to Overweight from Equal Weight with a price target of $89, up from $67. The firm believes the company’s Phase 1 update for myelofibrosis in Q4 will be positive. In addition, the potential for research and development “rationalization” along with future business development provides upside for the stock, the analyst tells investors in a research note. Wells believes Incyte can address its Jakafi loss of exclusivity.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1